High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset
- 19 September 2006
- journal article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (4), 537-541
- https://doi.org/10.1136/ard.2006.064782
Abstract
To investigate whether the cytokine-inducing properties of surface-bound collagen type II (CII)-containing immune complexes (IC), which were reported earlier, have any clinical impact. Anti-CII serology was analysed in 274 patients with early rheumatoid arthritis (RA). Patients with increased levels of anti-CII were followed serially for 1-5 years with regard to anti-CII IC-induced levels of tumour necrosis factor (TNF)alpha, interleukin (IL)1beta and IL8. Levels of antibodies and IC-induced cytokines were compared with clinical indices over 5 years of follow-up. 5/100 healthy controls and 24/274 (8.8%) patients with RA exhibited increased levels (>29 arbitrary units (AU)/ml) of anti-native CII antibodies, a non-significant difference. 9/274 (3.3%) patients with RA and no controls comprised a discrete group with high anti-CII levels>450 AU/ml. These high anti-CII level sera were associated with induction of pro-inflammatory cytokines by anti-CII-containing IC formed in vitro. 8/9 patients with high baseline anti-CII levels exhibited a parallel decline in antibody levels, IC-induced cytokines, C reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Anti-CII-positive patients had significantly increased levels of CRP and ESR at baseline, but not later during the follow-up. Anti-native CII-positive patients with RA have a distinct clinical phenotype characterised by an early acute phase response that might be driven by anti-CII-containing IC in joint cartilage.Keywords
This publication has 15 references indexed in Scilit:
- Surface‐bound anti–type II collagen–containing immune complexes induce production of tumor necrosis factor α, interleukin‐1β, and interleukin‐8 from peripheral blood monocytes via fcγ receptor IIA: A potential pathophysiologic mechanism for humoral anti–type II collagen immunity in arthritisArthritis & Rheumatism, 2006
- Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progressionAnnals Of The Rheumatic Diseases, 2005
- Epitope‐specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen‐induced arthritis in the mouseArthritis & Rheumatism, 2002
- Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progressionArthritis & Rheumatism, 1996
- Local anti—type ii collagen antibody production in rheumatoid arthritis synovial fluidArthritis & Rheumatism, 1994
- Specificity of antibodies to type II collagen in rheumatoid arthritisArthritis & Rheumatism, 1990
- DIVERSITY OF ANTIBODIES TO TYPE II COLLAGEN IN PATIENTS WITH RHEUMATOID ARTHRITIS: DETECTION BY BINDING TO α-CHAINS AND TO CYANOGEN BROMIDE PEPTIDESRheumatology, 1990
- Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritisArthritis & Rheumatism, 1989
- Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis.Annals Of The Rheumatic Diseases, 1987
- Anti-cartilage antibody.Journal of Clinical Pathology, 1979